Study Title
Comparison of F-18 FDG PET/CT and CT in Initial Staging of Non-small Lung Cancer
Study Details
Description:
Is to compare F-18 FDG PET/CT to routine CT in staging of non-small lung cancer and effect on change management.
Sponsor:
Assiut University
Contacts:
Nahla Moustafa (assistant professor)nahla_bashank_2006@yahoo.com
01009466255
Walaa Gamal (assistant lecturer)dr.walaa196@gmail.com
01065037395
Government Study Link:
NCT06789562 - Click here to see study onClinicalTrials.gov
Drug Details
18F-FDG
Isotope(s):
- FLUORINE-18
FLUORINE-18
Radioisotope: F-18
Theranostic Role: PET Imaging
T1/2 (Half-Life): 1.8 Hours
Decay Mode: POSITRON β+ (96.7%), ELECTRON CAPTURE (3.3%), GAMMA 511 keV
Energy: Eβ+ 635 keV
Range: N/A
Decay Daughters: O18 (Stable)
Status: FDA Approvals: FDG (Cancer 2005): GLUDEF®, METATRACE® AXUMIN® (2016), PYLARIFY® (2023), POSLUMA® (2024)
Target(s):
- Glucose Transport
